Characteristic | Overall (N = 69) | RVO group (N = 37) | Control group (N = 32) | p-value 1 | q-value 2 | |||
---|---|---|---|---|---|---|---|---|
95% CI | 95% CI | 95% CI 1 | ||||||
Age, mean (SD) | 60.16 (7.75) | 60.95 (8.43) | 58–64 | 59.25 (6.90) | 57–62 | 0.4 | 0.5 | |
Gender, n (%) | 0.08 | 0.15 | ||||||
F | 26 (37.68%) | 27–50% | 10 (27.03%) | 14–44% | 16 (50%) | 34–66% | ||
M | 43 (62.32%) | 50–73% | 27 (72.97%) | 56–86% | 16 (50%) | 34–66% | ||
IHD, n (%) | 18 (26.09%) | 17–38% | 11 (29.73%) | 16–47% | 7 (21.88%) | 9.9–40% | 0.6 | 0.7 |
DM, n (%) | 16 (23.19%) | 14–35% | 12 (32.43%) | 19–50% | 4 (12.50%) | 4.1–30% | 0.085 | 0.15 |
VA LogMAR, median (range) | 0.046 (0.0–0.155) | 0.097 (0.0–0.155) | 0.046 (0.0–0.097) | < 0.001 | < 0.001 | |||
INL lesions presence, n (%) | 30 (43.48%) | 32–56% | 26 (70.27%) | 53–84% | 4 (12.50%) | 4.1–30% | < 0.001 | < 0.001 |